Top-News

Durect Aktie News

Aktie
WKN:  A3DZZ2 ISIN:  US2666055007 US-Symbol:  DRRX Branche:  Pharmazeutika Land:  USA
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Marktkapitalisierung *
51,23 Mio. €
Streubesitz
63,75%
KGV
-2,81
Index-Zuordnung
Nasdaq Composite Index

Durect News

11.09.25 - PR Newswire
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-​stage Liver Disease Portfolio PR Newswire
18.08.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders PR Newswire
12.08.25 - PR Newswire
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health PR Newswire
31.07.25 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders PR Newswire
29.07.25 - PR Newswire
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease PR Newswire
13.05.25 - PR Newswire
DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update PR Newswire
26.03.25 - PR Newswire
DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update PR Newswire
19.03.25 - PR Newswire
DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update
DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update PR Newswire
04.02.25 - PR Newswire
DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference PR Newswire
28.01.25 - PR Newswire
DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence
DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence PR Newswire

Newssuche

Videos

newspaper
02.12.25 +8,18%
Technical Trading: DAX Long dienstags
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »